Search Results - "Silva Julian, Guilherme"

Refine Results
  1. 1

    Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study by Covas, Dimas Tadeu, de Jesus Lopes de Abreu, Ariane, Zampirolli Dias, Carolina, Vansan Ferreira, Rafaela, Gonçalves Pereira, Ramon, Silva Julian, Guilherme

    Published in PloS one (13-01-2023)
    “…By the fact that pregnant and postpartum women are currently using COVID-19 vaccines, ensure their safety is critical. So, more safety evidence is crucial to…”
    Get full text
    Journal Article
  2. 2

    Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review by Fardellone, Patrice, MD, Lello, Stefano, MD, Cano, Antonio, MD, de Sá Moreira, Eloisa, PhD, Watanabe de Oliveira, Renato, MS, Julian, Guilherme Silva, MS, Tang, Boxiong, MD

    Published in Clinical therapeutics (01-08-2019)
    “…AbstractPurposeBisphosphonate therapy is a well-established and effective treatment for postmenopausal osteoporosis and the prevention of osteoporotic…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era by Silva Julian, Guilherme, Spinardi, Júlia, Diaz-Puentes, Melissa, Buitrago, Diana, García, Ida Caterina, Kyaw, Moe H

    Published in Viruses (01-07-2024)
    “…We conducted a multicountry retrospective study using data from COVID-19 national surveillance databases to analyze clinical profiles, hospitalization rates,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Validation of housekeeping genes in the brains of rats submitted to chronic intermittent hypoxia, a sleep apnea model by Julian, Guilherme Silva, de Oliveira, Renato Watanabe, Perry, Juliana Cini, Tufik, Sergio, Chagas, Jair Ribeiro

    Published in PloS one (07-10-2014)
    “…Obstructive sleep apnea (OSA) is a syndrome characterized by intermittent nocturnal hypoxia, sleep fragmentation, hypercapnia and respiratory effort, and it…”
    Get full text
    Journal Article
  8. 8

    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach by Julian, Guilherme Silva, Rosim, Ricardo Papaléo, Carneseca, Estela Cristina, Rigolon, Jéssica

    Published in PloS one (02-03-2020)
    “…In the Brazilian public healthcare system, natalizumab is recommended as fourth-line treatment for relapsing-remitting multiple sclerosis (RRMS). Although…”
    Get full text
    Journal Article
  9. 9

    Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries by Julian, Guilherme Silva, Shau, Wen-Yi, Chou, Hsu-Wen, Setia, Sajita

    Published in JMIR medical informatics (15-08-2024)
    “…The economic trend and the health care landscape are rapidly evolving across Asia. Effective real-world data (RWD) for regulatory and clinical decision-making…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019 by Parellada, Cintia Irene, Abreu, Ariane de Jesus Lopes de, Birck, Marina G, Dias, Carolina Zampirolli, Moreira, Thais das Neves Fraga, Julian, Guilherme Silva, Batista, Paula de Mendonça, Orengo, Juan Carlos, Bierrenbach, Ana Luiza

    Published in Vaccines (Basel) (25-07-2023)
    “…The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal pneumococcal…”
    Get full text
    Journal Article
  12. 12

    The Impact of an Inactivated Hepatitis A Vaccine with One Dose in Brazil: A Retrospective Time-Series by Bierrenbach, Ana Luiza, Choi, Yoonyoung, Batista, Paula de Mendonça, Serra, Fernando Brandão, Parellada, Cintia Irene, Julian, Guilherme Silva, Nakajima, Karina, Moreira, Thais das Neves Fraga

    Published in Vaccines (Basel) (20-04-2021)
    “…In 2014, a recommended one-dose of inactivated hepatitis A vaccine was included in the Brazilian National Immunization Program targeting children 12-24 months…”
    Get full text
    Journal Article
  13. 13

    Analysis of the stability of housekeeping gene expression in the left cardiac ventricle of rats submitted to chronic intermittent hypoxia by Julian, Guilherme Silva, Oliveira, Renato Watanabe de, Tufik, Sergio, Chagas, Jair Ribeiro

    Published in Jornal brasileiro de pneumologia (01-05-2016)
    “…Obstructive sleep apnea (OSA) has been associated with oxidative stress and various cardiovascular consequences, such as increased cardiovascular disease risk…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Dinâmica e estrutura de acordos inovadores: uma avaliação dos casos de oncologia e imunologia by Gustavo Matsuno, Andreas Duva, Guilherme Silva Julian

    “…Introdução: Em meio a um cenário econômico desafiador, os acordos inovadores (AI) vem ganhando espaço no mercado farmacêutico brasileiro ao prometer maior…”
    Get full text
    Journal Article
  16. 16

    Modelo de advanced analytics de identificação de capacidade de atendimento de oncologia no SUS by Guilherme Silva Julian, Daniel Ferraz de Campos Filho

    “… Introdução: No Brasil, ainda existem diversas iniquidades de acesso à saúde. Especificamente em oncologia, existem maiores iniquidades, que podem variar com…”
    Get full text
    Journal Article
  17. 17

    Modelo de predição de risco de internação em pacientes com Diabetes mellitus tipo 2 atendidos na atenção primária de Curitiba – uma abordagem da inteligência artificial com machine learning by Guilherme Silva Julian, Daniel Ferraz de Campos Filho

    “…Introdução: O diabetes mellitus tipo 2 (DM2) é a doença mais prevalente mundialmente. Os agravamentos da DM2 geram um ônus econômico de até US$ 827 bilhões…”
    Get full text
    Journal Article
  18. 18

    Acordos inovadores no mundo: avaliação da experiência internacional by Andreas Duva, Gustavo Matsuno, Guilherme Silva Julian

    “…Introdução: A Incorporação da nusinersena no Sistema Único de Saúde atrelada a um acordo de compartilhamento de risco é um marco na história da CONITEC…”
    Get full text
    Journal Article
  19. 19

    Disparidades no tratamento do carcinoma de células renais no sus: padrões de tratamento, uso de recursos e custos relacionados ao tratamento by Guilherme Silva Julian, Andre Izelli, Gabriela Castilho, Luciaenne Neusquen, André Ballalai Ferraz

    “…Introdução: No Brasil, as disparidades entre os sistemas público e privado de saúde são significativas. Especificamente no sistema público de saúde (SUS),…”
    Get full text
    Journal Article
  20. 20

    Incorporação de medicamentos para doenças raras no SUS entre 2012 e 2018 by Pamela Karla Guimarães Santana, Jéssica Nacazume, Guilherme Silva Julian, André Ballalai

    “…Introdução: De acordo com a Organização Mundial da Saúde (OMS), doenças raras são aquelas que afetam até 65 pessoas a cada 100 mil indivíduos. Em 2015 foi…”
    Get full text
    Journal Article